Stay up to date on all things ATS 2025 International Conference. Check out latest news, key deadlines, and exciting program updates below. Don’t miss a beat… and see you in San Francisco, May 16-21, 2025!
-
Clinical Year in Review Series Begins with Insights on Asthma, Interventional Pulmonary, Pulmonary Function Tests, and Sleep
on 2025-05-30The first session of the Clinical Year in Review series began with an exploration of evolving concepts and practice-changing studies in asthma, interventional pulmonary medicine, pulmonary function tests, and sleep medicine on Sunday, May 18, at the ATS 2025 International Conference.
-
Second Clinical Year in Review Session Explores Practice-Changing Findings and Emerging Concepts in General Critical Care, Sepsis, and More
on 2025-05-30The Clinical Year in Review series continued at ATS 2025 San Francisco with an examination of studies with clinical practice implications, and a closer look at unresolved questions in general critical care, acute respiratory distress syndrome, and more on Monday, May 19.
-
Third Clinical Year in Review Session Traces the Leading Edge in Bronchiectasis, Interstitial Lung Disease, Lung Transplant, and Pulmonary Infections
on 2025-05-30Deep dives into the latest research and therapeutic advances in bronchiectasis, interstitial lung disease, lung transplant, and pulmonary infections were the focus of the third Clinical Year in Review series session on Tuesday, May 20, at ATS 2025 San Francisco.
-
Final Clinical Year in Review Session Highlights Advances in COPD, Pulmonary Vascular Disease, Pulmonary Rehabilitation, and Lung Cancer
on 2025-05-30The Clinical Year in Review series at the ATS 2025 International Conference concluded on Wednesday, May 21, with a discussion of impactful studies spanning pulmonary vascular disease, COPD, pulmonary rehabilitation, and lung cancer.
-
Experts Urge ATS Attendees to Take Action for Air Quality at Tuesday's Keynote
on 2025-05-21A panel of experts challenged ATS members and ATS 2025 International Conference attendees to help patients and regional leaders understand and act on the increasing importance of air quality for individuals and community health during Tuesday’s Keynote Series session, “Improving Air Quality and Health: Current Challenges and Opportunities."
-
Plenary Speaker Recounts Resilient Journey After Alpha-1 Antitrypsin Deficiency Diagnosis
on 2025-05-21Len Geiger was the featured speaker at the ATS 2025 International Conference Plenary Session on Tuesday. Diagnosed with Alpha-1 antitrypsin deficiency in 1994, Mr. Geiger has turned his personal health journey into a mission to educate, inspire, and drive meaningful change for others.
-
President’s Symposium Explores Many Facets of Underdiagnosed Alpha-1 Antitrypsin Deficiency
on 2025-05-21The “ATS President’s Symposium: Alpha-1 Breakthroughs: New Discoveries in Mechanisms, Diagnosis & Treatment of Lung Disease in Alpha-1 Antitrypsin Deficiency” examined critical gaps in knowledge about the disease on Monday at ATS 2025 San Francisco.
-
Pitch for Incentive Spirometry Device Wins 2025 BEAR Cage Competition
on 2025-05-21Yi-an Hsieh, MSE, and Joshua Freedman, MSE, co-founders of Airalux Medical, won the ATS 2025 BEAR Cage competition and a $10,000 prize on Monday for their pitch, "Digital Incentive Spirometer to Improve Patient Adherence and Clinical Workflows."
-
Early Career Programs Connect and Enrich Next Generation of Respiratory Medicine Professionals
on 2025-05-21More than 500 students and young professionals pursuing a career in pulmonary, critical care, and sleep medicine converged in San Francisco to attend the Early Career Programs at the ATS 2025 International Conference, where they learned about the latest technologies, scientific discoveries, and guidelines in the field.
-
ATS 2026 International Conference Call for Input Open Now
on 2025-05-21The ATS 2026 International Conference will take place May 15-20, 2026, in Orlando, but the call for input for next year’s conference has already opened! Submit your proposals for numerous International Conference programs in all areas of respiratory, critical care, and sleep medicine, with a clinical, basic science, and/or translational focus.